Eterna Therapeutics
ERNA
3 hedge funds and large institutions have $1.84M invested in Eterna Therapeutics in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
15% less capital invested
Capital invested by funds: $2.18M → $1.84M (-$338K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EAM
1
Eagle Asset Management
St Petersburg,
Florida
| $1.03M | – | – | – |
|
2
Renaissance Technologies
New York
| $239K | – | – | – |
|
|
SONJCPFA
3
State of New Jersey Common Pension Fund A
Trenton,
New Jersey
| $173K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $107K | – | – | – |
|
5
Dimensional Fund Advisors
Austin,
Texas
| $83K | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $59K | – | – | – |
|
|
BIT
7
BlackRock Institutional Trust
San Francisco,
California
| $43K | – | – | – |
|
|
OC
8
Oppenheimer & Co
New York
| $35K | – | – | – |
|
|
SKK
9
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| $35K | – | – | – |
|
10
Geode Capital Management
Boston,
Massachusetts
| $17K | – | – | – |
|
|
U
11
UBS
Zurich,
Switzerland
| $14K | – | – | – |
|
12
Northern Trust
Chicago,
Illinois
| $12K | – | – | – |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$12K | – | – |
|
ERNA Hedge Fund Activity: Q3 2013 in Review
3 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q3 2013, worth a combined $1.84M — down 15% from $2.18M a quarter earlier.
Fund positioning in ERNA was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $12K.
- 3 institutional investors held Eterna Therapeutics (ERNA) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $1.84M of Eterna Therapeutics stock for Q3 2013, down 15% quarter-over-quarter.
- 0 funds opened new Eterna Therapeutics positions in Q3 2013 and 0 closed out.
- The largest Eterna Therapeutics seller in Q3 2013 was Citadel Advisors, an estimated $12K sold.
Based on aggregated 13F filings for Q3 2013.